FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Ana Abecasis

Research Profile

Living Beings

HIV-1

Disorders

HIV Infections

Concepts & Ideas

Chemicals & Drugs

Physiology

Geographic Areas

Portugal

Procedures

Genes & Molecular Sequences

Genome, Viral

Occupations

Phylogeography

Co-author Network

Publications

TOP 3
Kristof Theys; Ana Abecasis; Anne-Mieke Vandamme
HIV-1 drug resistance: where do polymorphisms fit in?
K Theys; C Torti; Anne-Mieke Vandamme; J Vercauteren; M Zazzi; Ricardo Camacho; Bonaventura Clotet; Andrea De Luca; Z Grossman; E Schülter; Joke Snoeck; A Sönnerborg; D Struck; Ana Abecasis
HIV-1 subtype is an independent predictor of reverse transcriptase mutation K65R in HIV-1 patients treated with combination antiretroviral therapy including tenofovir.
K Theys; Anne-Mieke Vandamme; J Vercauteren; Ana Abecasis; Ricardo Camacho; Joke Snoeck
Decreasing population selection rates of resistance mutation K65R over time in HIV-1 patients receiving combination therapy including tenofovir.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Ana Abecasis (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Kristof Theys; Ana Abecasis; Anne-Mieke Vandamme
HIV-1 drug resistance: where do polymorphisms fit in?
Future microbiology 2013;8(3):303-6.
2013: K Theys; C Torti; Anne-Mieke Vandamme; J Vercauteren; M Zazzi; Ricardo Camacho; Bonaventura Clotet; Andrea De Luca; Z Grossman; E Schülter; Joke Snoeck; A Sönnerborg; D Struck; Ana Abecasis
HIV-1 subtype is an independent predictor of reverse transcriptase mutation K65R in HIV-1 patients treated with combination antiretroviral therapy including tenofovir.
Antimicrobial agents and chemotherapy 2013;57(2):1053-6.
2013: K Theys; Anne-Mieke Vandamme; J Vercauteren; Ana Abecasis; Ricardo Camacho; Joke Snoeck
Decreasing population selection rates of resistance mutation K65R over time in HIV-1 patients receiving combination therapy including tenofovir.
The Journal of antimicrobial chemotherapy 2013;68(2):419-23.
2012: Marcio Roberto Teixeira Nunes; Eliana Vieira Pinto da Silva; Sueli Guerreiro Rodrigues; Clayton Pereira Silva de Lima; Edivaldo Costa Sousa; Marc A Suchard; Helena Baldez Vasconcelos; Ana Abecasis; Jedson Ferreira Cardoso; Valéria Lima Carvalho; Nuno Rodrigues Faria; Philippe Lemey; Daniele Barbosa de Almeida Medeiros; Keley Nascimento Barbosa Nunes; Pedro Fernando da Costa Vasconcelos
Phylogeography of dengue virus serotype 4, Brazil, 2010-2011.
Emerging infectious diseases 2012;18(11):1858-64.
2012: Nuno R Faria; Ana Abecasis; Idalina Bonfim; Ricardo Camacho; Nicaise Ndembi; João D Sousa; Marc A Suchard; Anne-Mieke Vandamme; Philippe Lemey
Phylodynamics of the HIV-1 CRF02_AG clade in Cameroon.
Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases 2012;12(2):453-60.
2011: Ana Abecasis; Ricardo J Camacho; Ana P Carvalho; Inês Costa; Isabel Diogo; Perpétua Gomes; Andreia Martins
Molecular epidemiological analysis of paired pol/env sequences from Portuguese HIV type 1 patients.
AIDS research and human retroviruses 2011;27(7):803-5.
2011: Inês Bártolo; Pedro Borrego; Ricardo Camacho; Perpétua Gomes; Francine McCutchan; Ana Abecasis; Helena Barroso; Nuno Taveira
Origin and epidemiological history of HIV-1 CRF14_BG.
PloS one 2011;6(9):e24130.
2010: Ana Abecasis; Yunpeng Wang; Pieter Libin; Stijn Imbrechts; Tulio De Oliveira; Ricardo Camacho; Anne-Mieke Vandamme
Comparative performance of the REGA subtyping tool version 2 versus version 1.
Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases 2010;10(3):380-5.
2009: Kristof Theys; Jurgen Vercauteren; Ana Abecasis; Pieter Libin; Koen Deforche; Anne-Mieke Vandamme; Ricardo Camacho
The rise and fall of K65R in a Portuguese HIV-1 Drug Resistance database, despite continuously increasing use of tenofovir.
Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases 2009;9(4):683-8.
2009: André F A Santos; Ana Abecasis; Anne-Mieke Vandamme; Ricardo Camacho; Marcelo A Soares
Discordant genotypic interpretation and phenotypic role of protease mutations in HIV-1 subtypes B and G.
The Journal of antimicrobial chemotherapy 2009;63(3):593-9.
2008: Luis M F Gonzalez; André F A Santos; Ana Abecasis; Kristel Van Laethem; Esmeralda A J M Soares; Koen Deforche; Amilcar Tanuri; Ricardo Camacho; Anne-Mieke Vandamme; Marcelo A Soares
Impact of HIV-1 protease mutations A71V/T and T74S on M89I/V-mediated protease inhibitor resistance in subtype G isolates.
The Journal of antimicrobial chemotherapy 2008;61(6):1201-4.
2008: Yung Shwen Ho; Ana Abecasis; Kristof Theys; Koen Deforche; Dominic E Dwyer; Michael Charleston; Anne-Mieke Vandamme; Nitin K Saksena
HIV-1 gp120 N-linked glycosylation differs between plasma and leukocyte compartments.
Virology journal 2008;5():14.
2007: Ana Abecasis; Philippe Lemey; Nicole Vidal; Tulio De Oliveira; Martine Peeters; Ricardo Camacho; Beth Shapiro; Andrew Rambaut; Anne-Mieke Vandamme
Recombination confounds the early evolutionary history of human immunodeficiency virus type 1: subtype G is a circulating recombinant form.
Journal of virology 2007;81(16):8543-51.
2006: Perpétua Gomes; Ana Carolina Palma; Joaquim Cabanas; Ana Abecasis; Ana Patrícia Carvalho; Rainer Ziermann; Isabel Diogo; Fátima Gonçalves; Céu Sousa Lobo; Ricardo Camacho
Comparison of the COBAS TAQMAN HIV-1 HPS with VERSANT HIV-1 RNA 3.0 assay (bDNA) for plasma RNA quantitation in different HIV-1 subtypes.
Journal of virological methods 2006;135(2):223-8.
2006: Ana Abecasis; Koen Deforche; Lee Bacheler; Paula McKenna; Ana Patrícia Carvalho; Perpétua Gomes; Anne-Mieke Vandamme; Ricardo Camacho
Investigation of baseline susceptibility to protease inhibitors in HIV-1 subtypes C, F, G and CRF02_AG.
Antiviral therapy 2006;11(5):581-9.
2005: Ana Abecasis; Koen Deforche; Joke Snoeck; Lee Bacheler; Paula McKenna; Ana Patrícia Carvalho; Perpétua Gomes; Ricardo Camacho; Anne-Mieke Vandamme
Protease mutation M89I/V is linked to therapy failure in patients infected with the HIV-1 non-B subtypes C, F or G.
AIDS (London, England) 2005;19(16):1799-806.
2005: Ana Abecasis; Dimitrios Paraskevis; M Epalanga; M Fonseca; F Burity; J Bartolomeu; Ana Patrícia Carvalho; Perpétua Gomes; Anne-Mieke Vandamme; Ricardo Camacho
HIV-1 genetic variants circulation in the North of Angola.
Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases 2005;5(3):231-7.
2005: Dimitrios Paraskevis; Koen Deforche; Ana Abecasis; Ricardo Camacho; Anne-Mieke Vandamme
Analysis of complex HIV-1 intersubtype recombinants using a Bayesian scanning method.
Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases 2005;5(3):219-24.
2003: Perpétua Gomes; Ana Abecasis; Mercedes Almeida; Ricardo Camacho; Kamal Mansinho
Transmission of HIV-2.
The Lancet infectious diseases 2003;3(11):683-4.